I. Overview
The epilepsy specialty was initiated in 2001 as a treatment group under the Department of Neurology, led by Professor Zhang Jingjun with participation by Professor Li Tianfu and other staff. An independent epilepsy outpatient clinic was established in 2003.
In 2010, the Epilepsy Diagnosis and Treatment Center was accredited as a Shandong Provincial Key Medical and Health Discipline and serves as a regional epilepsy treatment center. The center currently has 23 professional staff members, including 8 chief physicians (professors) and 6 associate chief physicians (associate professors). Ten staff hold doctoral degrees, and 83% hold master’s degrees or above. The team includes 1 Young and Middle-aged Expert with Outstanding Contributions in Shandong Province and 2 high-level talents of the Shandong Provincial Health System. Many physicians have worked as senior visiting scholars at Harvard University in the United States, as well as institutions in Japan and the Republic of Korea.
II. Clinical Services and Technologies
The center runs an epilepsy outpatient clinic and inpatient ward. Standard medical therapy is routinely provided, with adjuvant traditional Chinese medicine for selected patients to achieve remarkable therapeutic effects. Sub-precise treatment is delivered for children at special developmental stages and pregnant patients.
The center routinely performs long-term video EEG monitoring and therapeutic drug monitoring of antiepileptic drugs. It is equipped with advanced instruments including 24-hour video EEG systems, somatosensory evoked potential‑electromyography systems, conventional EEG machines and central patient monitors, supporting high-quality medical services for patients.
The center has completed research on refractory epilepsy, genetic epilepsy and drug-resistant epilepsy. It has finished the epidemiological survey and prevention research of epilepsy in Shandong Province, and drafted the monograph Practical Epilepsy in Women.
III. Teaching and Talent Training
The discipline undertakes theoretical and practical teaching of neurology (epilepsy-related courses) for international students, doctoral students, master’s students, undergraduates and visiting physicians. It supervises postgraduate students specializing in epilepsy, with multiple master’s supervisors and nearly 60 graduates trained to date.
Through talent recruitment and in-house training, the center has built an academic team with high academic standards and a well-balanced structure of professional titles and ages, capable of undertaking national research projects and high-level scientific investigations. It also has a well-trained technical team proficient in operating advanced laboratory equipment to support clinical research. In the past three years, team members have attended 51 academic conferences at home and abroad, and 17 faculty members hold positions in national, provincial and municipal academic societies.
Professor Zhang Jingjun, the academic leader, is a second-grade professor, PhD and postgraduate supervisor. He has pursued further studies in Japan, Harvard University (USA), Saint Petersburg State Medical University (Russia) and McMaster University (Canada). His academic appointments include Member of the Epilepsy Committee of the Chinese Medical Doctor Association, Standing Committee Member of the Chinese Gerontological Society, Vice President of the Shandong Anti-Epilepsy Association, Vice President of the Shandong Behavioral Medicine Association, Director of the Epilepsy Treatment Center of Shandong Provincial Key Discipline, Vice Chairman of the Shandong Cerebrovascular Disease Prevention and Control Association, Vice Chairman of the Shandong Medical Informatics Association, First Session Famous Doctor of Shandong Province, Standing Director of the Shandong Medical Doctor Association, Young and Middle-aged Academic Backbone of Shandong Province, Key Talent of the Shandong Provincial Health System, and editorial board member of multiple journals.
He has presided over or participated in more than 40 research projects, won 4 provincial and ministerial awards and 19 departmental awards, published nearly 200 papers, co-authored 3 monographs and obtained 1 national patent. He was honored as Outstanding Scientific and Technological Worker of Shandong Province in 2011 and awarded a Second-Class Merit. He has supervised nearly 60 postgraduate students. With 30 years of experience in epilepsy research and clinical management, he participated in formulating Chinese epilepsy guidelines in 2015, including Guidelines for the Diagnosis and Treatment of Idiopathic Epilepsy (2015), Consensus on the Use of Antiepileptic Drugs in Pregnant Women, Expert Consensus on Vagus Nerve Stimulation for Epilepsy, and Chinese Expert Consensus on the Definition of Drug-Resistant Epilepsy.
He has conducted in-depth research on the pathogenesis and individualized management of epilepsy syndromes, genetic epilepsy, refractory epilepsy and epilepsy in women. He has treated tens of thousands of patients with epilepsy. The overall effective rate reaches 83%, close to the international best level of 84%, and the cure rate is nearly 70%. The outcomes have been appraised as internationally advanced. Many of his theories and research indicators have been cited in textbooks and authoritative journals, winning recognition from patients and peers. He has received honors including Outstanding Expert, Outstanding Research Worker, Top-notch Talent, Model Teacher and Outstanding Communist Party Member.
IV. Research and Academic Activities
The center maintains long-term exchange and collaborative research with four renowned overseas clinical trial centers and multiple domestic epilepsy centers, yielding fruitful clinical research results. In recent years, it has undertaken 38 research projects at departmental level and above, including National Natural Science Foundation of China and Shandong Provincial Natural Science Foundation projects. Sixteen research achievements have been identified, and 22 provincial and departmental awards have been obtained.
The center has a shared laboratory equipped with a cell culture room, video EEG recording systems, ultra-low temperature freezers, PCR instruments, fluorescence microscopes, refrigerated bench centrifuges and stabilized voltage/current electrophoresis apparatus. The laboratory supports animal experiments, specimen storage, real-time quantitative PCR, western blot and immunofluorescence histochemistry. It provides a complete experimental platform for research from gene and cellular levels to tissue and organ levels.
Epilepsy is a common disorder, and approximately 30% of cases are refractory epilepsy, which represents a key research focus worldwide. Major obstacles limiting epilepsy care include insufficient large-scale precise clinical data, innovative pathogenesis research and targeted prevention and treatment strategies. The center has carried out the following work to address these gaps:
Epidemiological research on epilepsy in Shandong Province. Large-scale epidemiological studies have confirmed that heredity, brain structural abnormalities, age and educational level are important risk factors for epilepsy. The treatment gap is 54%, indicating that most patients lack individualized prevention and treatment. This study provides critical baseline data on etiology, seizure types, treatment status and intervention strategies for epilepsy patients in this region, supporting precision epilepsy care in China. It has generated favorable social and economic benefits and filled the regional research gap.
In-depth research on epileptic mechanisms. ① Adenosine system regulating epileptic seizures: The team found that glial ADK expression plays a key role in glial fibrosis and neuronal dysfunction. Adenosine and adenosine kinase are validated as therapeutic targets for refractory epilepsy. The ketogenic diet suppresses seizures via adenosine A1 receptors. Regulation of ADK expression underlies the antiseizure effect of the ketogenic diet and represents a promising future therapeutic target. ② Brain network mechanisms of epilepsy initiation and propagation: The medial temporal lobe propagates epileptic activity to the lateral temporal lobe, frontal lobe, parietal lobe and thalamus, with modulation by the insula, putamen and thalamus. The findings reveal the core role of the medial temporal lobe in ictal discharge circuits. Thalamic activity is associated with spike-and-wave discharges in absence epilepsy, partly explaining impaired consciousness in childhood absence epilepsy. ③ Chloride homeostasis in seizure control: Hippocampal neuronal chloride concentration is mainly mediated by NKCC1 and KCC2 chloride transporters. WNK kinases regulate intracellular chloride via the SPAK/OSR1 signaling pathway. WNK kinase inhibitors represent a potential therapeutic strategy for temporal lobe epilepsy. ④ Biobank platform based on the Shandong Provincial Key Discipline Epilepsy Center: A resource bank of thousands of epilepsy patients has been established. Twenty-one types of genetic epilepsy and 18 subtypes of refractory epilepsy have been investigated. The team explores differential RNA expression, target genes, signaling pathways, metabolic networks and specific RNA biomarkers for early diagnosis, laying a foundation for precision diagnosis.
Precision prevention and treatment for epilepsy patients. The center has investigated the optimal effective doses, therapeutic blood concentrations, antiepileptic spectra, drug interaction mechanisms, relationships between serum levels and epileptiform discharges, toxic mechanisms and dynamic gestational blood concentration profiles of selected antiepileptic drugs in Chinese populations. Evidence-based studies compare the efficacy of newer and older antiepileptic drugs for refractory epilepsy, and analyze the correlation between postoperative histopathology, lesion localization and surgical outcomes, providing theoretical support for precision management.
Dissemination, application and socioeconomic impact. More than 300 related papers have been published with a total citation count of 826. Professor Zhang Jingjun has been invited nearly 20 times to deliver keynote lectures at domestic and international conferences on topics including Epilepsy in Women, Genetic Epilepsy, Refractory Epilepsy, and Reflections on the Development of Epilepsy Research, reaching more than 3,000 participants. He has repeatedly chaired academic meetings of the Epilepsy Committee of the Neurology Branch of the Chinese Medical Doctor Association. His research findings have been adopted by Practical Epileptology and the 2015 Epilepsy Committee of the Chinese Medical Doctor Association. Selected results have been translated into clinical practice to promote precision epilepsy care and deliver substantial social benefits.
Tel: 0538-6237426 (Outpatient Clinic)0538-6237428 (Inpatient Ward)